# EDGAR Filing Document

**Accession Number:** 0001564406
**File Stem:** 0000000000-23-002679
**Filing Date:** 2023-3
**Character Count:** 6358
**Document Hash:** a352b1a216d934c895952e42894efd49
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-23-002679.hdr.sgml**: 20230522

**ACCESSION NUMBER**: 0000000000-23-002679

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230317

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Oak Street Health, Inc.
- **CENTRAL INDEX KEY:** 0001564406
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HEALTH SERVICES [8000]
- **IRS NUMBER:** 843446686
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD

**BUSINESS ADDRESS:**
- **STREET 1:** 30 W. MONROE ST., STE. 1200
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60603
- **BUSINESS PHONE:** 312-773-3374

**MAIL ADDRESS:**
- **STREET 1:** 30 W. MONROE ST., STE. 1200
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60603

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Oak Street Health, LLC
- **DATE OF NAME CHANGE:** 20121211
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001193125-23-064913

## Text-Extract

```

United States securities and exchange commission logo

                            March 17, 2023

       Mike Pykosz
       Chief Executive Officer
       Oak Street Health, Inc.
       30 W. Monroe Street, Suite 1200
       Chicago, Illinois 60603

                                                        Re: Oak Street Health,
Inc.
                                                            Preliminary Proxy
on Schedule 14A
                                                            Filed March 9, 2023
                                                            File No. 001-39427

       Dear Mike Pykosz:

              We have reviewed your filing and have the following comment. In
our comment we may
       ask you to provide us with information so we may better understand your
disclosure.

              Please respond to this comment within ten business days by
providing the requested
       information or advise us as soon as possible when you will respond. If
you do not believe our
       comment applies to your facts and circumstances, please tell us why in
your response.

                                                        After reviewing your
response to this comment, we may have additional comments.

       Preliminary Proxy on Schedule 14A, Filed March 9, 2023

       General

   1.                                                   It appears that Mike
Pykosz, the company   s Chief Executive Officer, Chairman and
                                                        Director, will remain
the Chief Executive Officer of the company upon the closing of the
                                                        transaction. Please
tell us the role of the CEO and possibly other senior management who
                                                        were involved in the
negotiations and why you believe no such person is an affiliate
                                                        engaged, directly or
indirectly, in the going private transaction. For guidance, refer to
                                                        Questions 201.01 and
201.05 of the Division of Corporation Finance   s Compliance and
                                                        Disclosure
Interpretations of Going Private Transactions, Exchange Act Rule 13e-3, and
                                                        Schedule 13E-3.
 Mike Pykosz
FirstName
Oak Street LastNameMike Pykosz
           Health, Inc.
Comapany
March      NameOak Street Health, Inc.
       17, 2023
March2 17, 2023 Page 2
Page
FirstName LastName
        We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence of
action by the staff.

       You may contact Jordan Nimitz at 202-551-5831 or Celeste Murphy at
202-551-3257
with any questions.

                                                          Sincerely,

                                                          Division of
Corporation Finance
                                                          Office of Industrial
Applications and
                                                          Services
cc:      Daniel Wolf, Esq.

```

### Attached PDF Documents

**Attachment 1:** `filename1`

![img-0.jpeg](img-0.jpeg)

CORPORATION FINANCE

# UNITED STATES  
SECURITIES AND EXCHANGE COMMISSION  
WASHINGTON, D.C. 20549

March 17, 2023

Mike Pykosz  
Chief Executive Officer  
Oak Street Health, Inc.  
30 W. Monroe Street, Suite 1200  
Chicago, Illinois 60603

**Re: Oak Street Health, Inc.  
Preliminary Proxy on Schedule 14A  
Filed March 9, 2023  
File No. 001-39427**

Dear Mike Pykosz:

We have reviewed your filing and have the following comment. In our comment we may ask you to provide us with information so we may better understand your disclosure.

Please respond to this comment within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe our comment applies to your facts and circumstances, please tell us why in your response.

After reviewing your response to this comment, we may have additional comments.

Preliminary Proxy on Schedule 14A, Filed March 9, 2023

# General

1. It appears that Mike Pykosz, the company’s Chief Executive Officer, Chairman and Director, will remain the Chief Executive Officer of the company upon the closing of the transaction. Please tell us the role of the CEO and possibly other senior management who were involved in the negotiations and why you believe no such person is an affiliate engaged, directly or indirectly, in the going private transaction. For guidance, refer to Questions 201.01 and 201.05 of the Division of Corporation Finance’s Compliance and Disclosure Interpretations of Going Private Transactions, Exchange Act Rule 13e-3, and Schedule 13E-3.

Mike Pykosz
Oak Street Health, Inc.
March 17, 2023
Page 2

We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

You may contact Jordan Nimitz at 202-551-5831 or Celeste Murphy at 202-551-3257 with any questions.

Sincerely,

Division of Corporation Finance
Office of Industrial Applications and
Services

cc: Daniel Wolf, Esq.